CBS Early Career Investigator Award Winner
0 comments
by Nima Khadem Mohtaram
We are very pleased to inform you that Dr. Marc A. Gauthier has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Early Career Investigator Award, acknowledging his outstanding contributions to our Society...
Dear CBS Members, As you are aware, the COVID-19 pandemic has caused numerous disruptions around the world, and scheduled conferences are being either postponed or canceled...
Winner of CBS Lifetime Achievement Award
0 comments
by Nima Khadem Mohtaram
We are very pleased to inform you that Dr. Paul Santerre has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Lifetime Achievement Award , acknowledging his outstanding contributions to our Society...
CBS is pleased to offer travel awards to assist students and post-doctoral fellows who are CBS members to present their accepted oral or poster abstracts at the 11th World Biomaterials Congress this May in Glasgow, Scotland...
Patients with chronic kidney disease usually have a higher level of protein carbamylation than healthy people, which is strongly associated with cardiac damage, congestive heart failure, and sudden cardiac death...
The transcription factor Ascl1 plays a key role in neural development. Recently Ascl1 was identified as a pioneer factor capable of reprogramming other cell types of the central nervous system into neurons using viral mediated overexpression1...
Calcium phosphate and chlorhexidine - releasing, high strength light-cured composites which promotes hydroxyapatite and antibacterial co-precipitation
comments
Dental composites have been used for over 50 years as restorative materials. Compared with dental amalgam, these trigger less safety concerns and provide improved aesthetics...
Generally, drug molecules are associated with low solubility in physiological media, rapid metabolism or undesired interaction with proteins present in the blood including enzymes and antibodies...
Current therapies with tyrosine kinase inhibitors such as Imatinib against Chronic Myeloid Leukemia CML inhibit production of 99 of fast-dividing cells, which are mostly the ones that remain in suspension through out the circulation system...
